Apple Q2 Beat
Apple delivered a record revenue and EPS beat for Q2 FY2026, underscoring the resilience of its product ecosystem [2]. Management guided June quarter revenue growth of 14%‑17%, well above consensus, and announced an expanded buyback and dividend program [2]. The company highlighted Mac supply constraints as a short‑term headwind, but said inventory levels remain manageable [2][3]. Investor sentiment turned sharply positive, pushing AAPL higher and reinforcing the tech megacap rally that dominated the month.
CEO Transition Outlook
Apple confirmed that John Ternus will assume the CEO role on September 1, marking the first leadership change since Tim Cook’s tenure began [2]. Analysts view the transition as a smooth succession, given Ternus’s long‑standing product leadership, but note potential strategic shifts in services and AR/VR pipelines. The guidance and buyback announcements helped mitigate any uncertainty, keeping the stock’s upside intact. Market participants will watch the post‑transition earnings call for clues on execution risk and any changes to capital allocation.
Fed Decision & Inflation
Asian investors, including those in Australia and Japan, are eyeing the Fed’s policy decision slated for Wednesday night, after the United States releases its May inflation data [1]. The Fed’s stance on rates will likely set the tone for global risk appetite, with a dovish tilt expected to buoy equities and a hawkish outcome potentially curbing the recent rally. The May CPI report is the key data point that will clarify whether inflation pressures are easing. Traders are positioning for a post‑Fed swing in both equity and currency markets.
Geopolitical Backdrop
Despite escalating tensions surrounding the Iran war, markets in the Asia‑Pacific region managed to climb higher on the back of strong earnings and supportive monetary policy expectations [1]. Investors appear to be discounting short‑term geopolitical risk in favor of fundamental drivers, though volatility spikes remain a possibility. The narrative of “risk‑on” persisted, aided by the anticipation of a favorable Fed outcome. Nonetheless, analysts caution that any sudden escalation could quickly reverse the modest gains seen this month.
Healthcare Gains via Veeva
Veeva Systems is set to join the S&P 500 on May 7, replacing Coterra Energy, a move that is expected to trigger ETF‑driven buying pressure on the stock [4]. The inclusion highlights the growing weight of healthcare within the broader index and may prompt a modest rotation from high‑growth tech to more defensive sectors. Veeva’s cloud‑based solutions for life‑sciences firms position it as a beneficiary of continued industry digitization. Investors should monitor the initial rebalancing flows for early price action and potential spillover into related healthcare names.